Last reviewed · How we verify

NCT07016191

Effect of Super-Oxygenated Water on Blood Oxygen Saturation

Completed NA Results posted Last updated 27 January 2026
What this trial tests

NA trial testing Ingestion of Water in Adult Subject in 60 participants. Completed in 28 November 2025.

Timeline
1 May 2025
Primary endpoint
26 November 2025
28 November 2025

Quick facts

Lead sponsorInhale, Inc
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeother
Enrollment60
Start date1 May 2025
Primary completion26 November 2025
Estimated completion28 November 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Inhale, Inc

Who can join

18 and older, any sex, with Adult Subject. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

SpO2 Response Rate Primary · From pre-ingestion to post-ingestion of water

Number of participants who experienced an improvement in post-ingestion SpO2. An increase in post-ingestion SpO2 over the pre-ingestion level in the same subject was considered a response.

GroupValue95% CI
Inhale Super-Oxygenated Water21± 0.5404
Placebo Control11± 0.3117
Heart Rate Response Rate Primary · From pre-ingestion to post-ingestion of water

Number of participants who experienced a reduction in post-ingestion heart rate. A decrease in post-ingestion heart rate over the pre-ingestion level in the same subject was considered a response.

GroupValue95% CI
Inhale Super-Oxygenated Water21± 2.603
Placebo Control14± 1.347
Energy Level Response Rate Secondary · From pre-ingestion to post-ingestion of water

Number of participants who reported an improvement in post-ingestion energy level. An increase in post-ingestion energy level over the pre-ingestion level in the same subject was considered a response. Energy level was measured by a participant-reported questionnaire titled "Energy Level and Brain Clarity Assessment" with possible scores ranging from 1 (meaning "very-low") through 10 (meaning "very-high") where higher score indicated a greater energy level.

GroupValue95% CI
Inhale Super-Oxygenated Water17± 7.520
Placebo Control6± 3.278
Brain Clarity Response Rate Secondary · From pre-ingestion to post-ingestion of water

Number of participants who reported an improvement in post-ingestion brain clarity. An increase in post-ingestion brain clarity over the pre-ingestion level in the same subject was considered a response. Brain clarity was measured by a participant-reported questionnaire titled "Energy Level and Brain Clarity Assessment" with possible scores ranging from 1 (meaning "very-low") through 10 (meaning "very-high") where higher score indicated a greater brain clarity.

GroupValue95% CI
Inhale Super-Oxygenated Water15± 3.827
Placebo Control5± 3.519

Sponsor's own description

Therapeutic delivery of additional Oxygen to blood stream via hyperbaric and extracorporeal oxygenation that raises blood Oxygen saturation level, apart from oxygenation in the lungs, is known to induce tissue repair, restore normal body functions and improve survival. Despite the clinical benefits obtained from these interventions, Oxygen supplementation is rather a medically involved process requiring access to specialized equipment including hyperbaric chambers, cardiac catheterization laboratory and extracorporeal oxygenators, and is not generally amenable for everyday use. The current prospective study will evaluate a non-invasive route for Oxygen delivery through ingestion of super-oxygenated water in adult volunteers. The participants will be randomly assigned to one of the two study groups viz. Inhale super-oxygenated water or placebo control normal water at 1:1 ratio. Neither the participants nor the study doctor will know the treatment assignment. Pre- and post-ingestion measurements will be conducted to evaluate effect of super-oxygenated water.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07016191.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing